Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2019 | Pages:
116 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)
The U.S. home infusion therapy market size is expected to reach USD 17.8 billion by 2026, registering a CAGR of 4.9% during the forecast period, according to a new report by Grand View Research, Inc. Rising geriatric population and prevalence of health conditions such as cancer, immune deficiencies, Crohn's disease, infections, dehydration, nutritional deficiencies, multiple sclerosis, and gastrointestinal diseases is driving the demand for home infusion therapy in the country. Growing cases of Hospital Acquired Infections (HAI) is another major driver for the U.S. market for home infusion therapy. According to the US Center for Disease Control and Prevention (CDC), annually, approximate 1.7 million admitted patients are affected by Health Care-associated infections (HCAI) and around 98,000 patients-one in every 17 patients- die due to HCAIs. This factor is anticipated to substantially drive the demand for home infusion therapy. Increasing innovations in home infusion therapy such as, incorporation of Electronic Healthcare Records (EHR) along with medical devices and infusion pumps are expected to further fuel the market in the forthcoming years. The EHRs allow storage, retrieval, and alteration of medical records, making it easier for healthcare professionals and patients to track improvements in the particular health condition. Increasing preference for home healthcare owing to its cost-efficiency over hospital stay is expected to create an opportunity for the industry players to launch more innovative products. Also, the introduction of safety products will ultimately help the growth of the U.S. home infusion therapy market. Further key findings from the report suggest: • Infusion pumps segment held the largest market share in 2018, due to increasing use and efficiency in delivering required quantities of nutrition, medications, and other essential fluids • Needleless connectors is anticipated to lead the product segment with the fastest CAGR over the forecast period owing to various benefits, such as reduced risk of bacterial contamination and higher protection against needlestick injuries • Anti-infective application segment held the maximum share of the U.S. home infusion therapy market in 2018 owing to extensive use as antifungal, antibiotics, and antiviral agents at home care • Endocrinology application is projected to register the fastest CAGR over the forecast period, owing to growing number of conditions associated with endocrine system, such as thyroid and diabetes • Some of the key market players include B. Braun Melsungen; Baxter International; Caesarea Medical Electronics Ltd.; CareFusion; Fresenius Kabi; ICU Medical; JMS CO., LTD.; Smiths Medical, Inc.; Terumo Corporation; Coram LLC; Option Care Enterprises, Inc.; BioScrip, Inc.; BriovaRx Infusion Services; and Paragon Healthcare
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database:
1.3.2 Gvr's Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective 1
1.8.2 Objective 2
1.8.3 Objective 3
1.8.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Penetration & Growth Prospect Mapping
2.3 Market Dynamics
2.3.1 Market Driver Analysis
2.3.1.1 Increasing geriatric population
2.3.1.2 Rising prevalence of chronic disorders
2.3.1.3 Rapid technological advancements
2.3.1.4 Growing incidence of hospital acquired infections
2.3.1.5 Home healthcare as cost effective alternative
2.3.2 Market Restrain Analysis
2.3.2.1 Presence of complicated reimbursement framework and reimbursement cuts
2.3.3 Impact Of The 21st Century Cures Act And Projections For The Impact Of The Bipartisan Budget Act Of 2018.
2.3.4 Trends For Home Infusion For Medicare Part B And Medicare Part D
2.4 Home Infusion Therapy: Market Analysis Tools
2.4.1 Industry Analysis - Porter's
2.4.2 Pestle Analysis
2.5 U.S Home Infusion Therapy- Company Market Share Analysis 2018
2.6 Major Deals & Strategic Alliances Analysis
2.7 Procedure cost analysis/breakdown
2.8 Technology Timeline
2.9 Regulatory Framework
2.10 Reimbursement framework
Chapter 3 Home Infusion Therapy Market: Segment Analysis, By Product, 2014 - 2026 (USD Million)
3.1 Product Market Share Analysis, 2018 & 2026
3.2 U.S. Home Infusion Therapy Market, by Product, 2014 to 2026
3.3 Market Size & Forecasts and Trend Analyses, 2014 to 2026
3.3.1 Infusion Pumps
3.3.1.1 Infusion Pumps Market, 2014 - 2026 (USD Million)
3.3.1.2 Ambulatory Infusion Pumps Market, 2014 - 2026 (USD Million)
3.3.1.3 Insulin Pumps Market, 2014 - 2026 (USD Million)
3.3.1.4 Syringe Pumps Market, 2014 - 2026 (USD Million)
3.3.1.5 Elastomeric Pumps Market, 2014 - 2026 (USD Million)
3.3.1.6 Patient Controlled Analgesics (Pca) Market, 2014 - 2026 (USD Million)
3.3.1.7 Volumetric Pumps Market, 2014 - 2026 (USD Million)
3.3.2 Intravenous Sets
3.3.3 Intravenous Sets Market, 2014 - 2026 (USD Million)
3.3.4 Gravity Sets Market, 2014 - 2026 (USD Million)
3.3.5 Dedicated Sets Market, 2014 - 2026 (USD Million)
3.3.6 Iv Cannulas
3.3.6.1 Iv Cannulas Market, 2014 - 2026 (USD Million)
3.3.7 Needleless Connectors
3.3.7.1 Needleless Connectors Market, 2014 - 2026 (USD Million)
Chapter 4 Home Infusion Therapy Market: Segment Analysis, By Application, 2014 - 2026 (USD Million)
4.1 Application Market Share Analysis, 2018 & 2026
4.2 U.S. Home Infusion Therapy Market, by Application, 2014 to 2026
4.3 Market Size & Forecasts and Trend Analyses, 2014 to 2026
4.3.1 Anti-Infective
4.3.1.1 Anti-infective market, 2014 - 2026 (USD Million)
4.3.2 Endocrinology
4.3.2.1 Endocrinology Market, 2014 - 2026 (USD Million)
4.3.2.2 Diabetes Market, 2014 - 2026 (USD Million)
4.3.2.3 Others Market, 2014 - 2026 (USD Million)
4.3.3 Hydration Therapy
4.3.3.1 hydration therapy market, 2014 - 2026 (USD Million)
4.3.3.2 Athletes market, 2014 - 2026 (USD Million)
4.3.3.3 Others market, 2014 - 2026 (USD Million)
4.3.4 Chemotherapy
4.3.4.1 Chemotherapy MARKET, 2014 - 2026 (USD Million)
4.3.5 Enteral Nutrition
4.3.5.1 Enteral Nutrition Market, 2014 - 2026 (USD Million)
4.3.6 Parenteral Nutrition
4.3.6.1 Parenteral Nutrition Market, 2014 - 2026 (USD Million)
4.3.7 Specialty Pharmaceuticals
4.3.7.1 Specialty Pharmaceuticals Market, 2014 - 2026 (USD Million)
4.3.8 Others
4.3.8.1 Others market, 2014 - 2026 (USD Million)
Chapter 5 Home Infusion Therapy Market: Country Market Analysis, By Product, 2014 - 2026 (USD Million)
5.1 Market Size, & Forecasts and Trend Analysis, 2018 to 2026
5.2 U.S.
5.2.1 U.S. Home Infusion Therapy Market, By Product, 2014 - 2026 (USD Million)
5.2.2 U.S. Home Infusion Therapy Market, By Application, 2014 - 2026 (USD Million)
Chapter 6 Home Infusion Therapy Market - Competitive Analysis
6.1 Competitive Dashboard Analysis - Impact Analysis
6.1.1 Recent Developments & Impact Analysis, By Key Market Participants
6.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
6.2.1 List Of Key Innovators
6.2.2 List Of Market Leader
6.2.3 List Of Emerging Players
6.3 Company market position analysis (Revenue, product portfolio, key serviceable industries, key alliances)
6.3.1 By Revenue
6.4 Strategy Framework
6.5 Company Profiles
6.5.1 B. BRAUN MELSUNGEN AG
6.5.1.1 Company overview
6.5.1.2 Financial performance
6.5.1.3 Product benchmarking
6.5.1.4 Strategic initiatives
6.5.2 BAXTER
6.5.2.1 Company overview
6.5.2.2 Financial performance
6.5.2.3 Product benchmarking
6.5.2.4 Strategic initiatives
6.5.3 CAESAREA MEDICAL ELECTRONICS
6.5.3.1 Company overview
6.5.3.2 Product benchmarking
6.5.3.3 Strategic initiatives
6.5.4 CAREFUSION CORPORATION
6.5.4.1 Company overview
6.5.4.2 Financial performance
6.5.4.3 Product benchmarking
6.5.4.4 Strategic initiatives
6.5.5 FRESENIUS KABI AG
6.5.5.1 Company overview
6.5.5.2 Financial performance
6.5.5.3 Product benchmarking
6.5.5.4 Strategic initiatives
6.5.6 ICU MEDICAL, INC.
6.5.6.1 Company overview
6.5.6.2 Financial performance
6.5.6.3 Product benchmarking
6.5.6.4 Strategic initiatives
6.5.7 JMS CO., LTD.
6.5.7.1 Company overview
6.5.7.2 Financial performance
6.5.7.3 Product benchmarking
6.5.8 SMITHS MEDICAL
6.5.8.1 Company overview
6.5.8.2 Financial performance
6.5.8.3 Product benchmarking
6.5.8.4 Strategic initiatives
6.5.9 TERUMO CORPORATION
6.5.9.1 Company overview
6.5.9.2 Financial performance
6.5.9.3 Product benchmarking
6.5.9.4 Strategic initiatives
6.5.10 CORAM LLC
6.5.10.1 Company overview
6.5.10.2 Product benchmarking
6.5.11 OPTION CARE ENTERPRISES, INC.
6.5.11.1 Company overview
6.5.11.2 Financial performance
6.5.11.3 Product benchmarking
6.5.11.4 Strategic initiatives
6.5.12 BIOSCRIP, INC.
6.5.12.1 Company overview
6.5.12.2 Financial performance
6.5.12.3 Product benchmarking
6.5.12.4 Strategic initiatives
6.5.13 BRIOVARX INFUSION SERVICES
6.5.13.1 Company overview
6.5.13.2 Financial performance
6.5.13.3 Product benchmarking
6.5.13.4 Strategic initiatives
6.6. PARAGON HEALTHCARE, INC.
6.6.1 Company overview
6.6.2 Financial performance
6.6.3 Product benchmarking
List of Tables Table 1 List of secondary sources Table 2 U.S. Home Infusion Therapy market, leading market players per region Table 3 U.S. Home Infusion Therapy market, Regional Network Map Table 4 U.S. Home Infusion Therapy market, market differentiating factor Table 5 U.S. Home Infusion Therapy market, By Product, 2014 - 2026 (USD Million) Table 6 U.S. Home Infusion Therapy market, By Application, 2014 - 2026 (USD Million)
List of Figures Fig. 1 U.S. home infusion therapy market segmentation Fig. 2 Market research process Fig. 3 Information procurement Fig. 4 Primary research pattern Fig. 5 Market research approaches Fig. 6 Value-chain-based sizing & forecasting Fig. 7 QFD modeling for market share assessment Fig. 8 Market formulation & validation Fig. 9 Commodity flow analysis Fig. 10 Market outlook (2018) Fig. 11 Penetration & growth prospect mapping Fig. 12 Market driver relevance analysis (Current & future impact) Fig. 13 U.S. population over 60 years by age, 1900 - 2050 Fig. 14 Prevalence of chronic disease in the U.S. Fig. 15 Treatment cost by healthcare setting (Average cost per day in USD) Fig. 16 Market restraint relevance analysis (Current & future impact) Fig. 17 Porter's five forces analysis Fig. 18 PESTLE analysis Fig. 19 U.S. Home Infusion Therapy market: Company market share analysis, 2018 Fig. 20 U.S. Home Infusion Therapy market: Company market share analysis, 2018 Fig. 21 U.S. home infusion therapy market: Product movement analysis Fig. 22 U.S. home infusion therapy market product outlook: Key takeaways Fig. 23 Infusion pumps market, 2014 - 2026 (USD Million) Fig. 24 Ambulatory infusion pumps market, 2014 - 2026 (USD Million) Fig. 25 Insulin pumps market, 2014 - 2026 (USD Million) Fig. 26 Syringe pumps market, 2014 - 2026 (USD Million) Fig. 27 Elastomeric pumps market, 2014 - 2026 (USD Million) Fig. 28 Patient controlled analgesics market, 2014 - 2026 (USD Million) Fig. 29 Volumetric pumps market, 2014 - 2026 (USD Million) Fig. 30 Intravenous sets market, 2014 - 2026 (USD Million) Fig. 31 Intravenous sets market, 2014 - 2026 (USD Million) Fig. 32 Dedicated sets market, 2014 - 2026 (USD Million) Fig. 33 IV cannulas market, 2014 - 2026 (USD Million) Fig. 34 Needleless connectors market, 2014 - 2026 (USD Million) Fig. 35 U.S. home infusion therapy market: Application movement analysis Fig. 36 Home infusion therapy market application outlook: Key takeaways Fig. 37 Anti-infective market, 2014 - 2026 (USD Million) Fig. 38 Endocrinology market, 2014 - 2026 (USD Million) Fig. 39 Diabetes market, 2014 - 2026 (USD Million) Fig. 40 Others market, 2014 - 2026 (USD Million) Fig. 41 Hydration therapy market, 2014 - 2026 (USD Million) Fig. 42 Athletes market, 2014 - 2026 (USD Million) Fig. 43 Others market, 2014 - 2026 (USD Million) Fig. 44 Chemotherapy market, 2014 - 2026 (USD Million) Fig. 45 Enteral nutrition market, 2014 - 2026 (USD Million) Fig. 46 Parenteral nutrition market, 2014 - 2026 (USD Million) Fig. 47 Specialty pharmaceuticals market, 2014 - 2026 (USD Million) Fig. 48 Others market, 2014 - 2026 (USD Million) Fig. 49 U.S. Fig. 50 U.S. home infusion therapy market, by product, 2014 - 2026 (USD Million) Fig. 51 U.S. home infusion therapy market, by application, 2014 - 2026 (USD Million) Fig. 52 Recent Developments & Impact Analysis Fig. 53 Strategy Framework
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
